ANDA 062231

PARKE DAVIS

FDA Drug Application

Application #062231

Application Sponsors

ANDA 062231

PARKE DAVIS

Marketing Status

• Discontinued: 001
• Discontinued: 002

Application Products

001	SUSPENSION;ORAL	EQ 200MG BASE/5ML	0	ERYTHROMYCIN ETHYLSUCCINATE	ERYTHROMYCIN ETHYLSUCCINATE
002	SUSPENSION;ORAL	EQ 400MG BASE/5ML	0	ERYTHROMYCIN ETHYLSUCCINATE	ERYTHROMYCIN ETHYLSUCCINATE

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62231
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)